• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Newsletters » The CenterWatch Monthly

The CenterWatch Monthly Subscribe

January 3, 2023

View Archived Issues

Download Current Issue:

  • January 2023 (Vol. 30, Issue 01)
eu-flag.gif

EU-CTR Faces Rough Transition Amid Industry Concerns

The two-year transition to the new EU Clinical Trials Regulation (EU-CTR), set to begin Jan. 31, 2023, may be off to a rocky start, according to several experts that attribute much of the concern to the function of the Clinical Trials Information System (CTIS) at the heart of the new regulatory scheme.

Read More
six-steps.gif

Six Steps to Optimizing SOP Development and Use

Standard operating procedures (SOP) are not just necessary for keeping a trial on track, they are mandatory for the FDA and the first documents requested during an inspection. They must be clear, comprehensive and — most important — followed to the letter if a site is to survive close scrutiny. 

Read More

EU Paper Tasks Sponsors, Investigators with Oversight of Decentralized Trial Data

In trials using decentralized elements, sponsors and investigators have ultimate responsibility for ensuring the integrity of the data generated, says a draft EU guideline, placing additional oversight duties on their plates.

Read More

FDA Issues Updated Guidance on Developing Pulmonary Tuberculosis Drugs

The FDA says a single, well-controlled trial may be used to support a drug candidate for treatment of pulmonary tuberculosis (TB) if additional confirmatory evidence is available, in a revised draft guidance.

Read More

FDA Proposes More Detailed Annual Reporting for INDs

The FDA has issued two proposed rules on investigational new drug applications (IND) that would require more detailed IND reports and exemptions for clinical trials for drug uses of a food, dietary supplement or cosmetic product.

Read More

FDA Adopts ICH E19 Guidelines on Selective Safety Data Gathering

In an effort to improve the efficiency of late-stage and post-approval trials, the FDA has endorsed the International Council for Harmonization’s (ICH) E19 guidelines, which offer considerations for selectively collecting safety data, in recent final guidance.

Read More

EMA Plans New Guidance in Response to Increased Use of Platform Trials

The European Medicines Agency (EMA) is planning to draft new guidance on the planning, operational and reporting challenges inherent to platform trials.

Read More

Study Lead Opportunities

New Study Lead Opportunities from Cytokinetics, Genentech and NETRIS Pharma.

Read More

FDA Actions

New FDA Actions from AstraZeneca, BioCardia and Jazz Pharmaceuticals. 

Read More

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing